News & Updates

Show Multimedia Only

Dupilumab improves quality of life in atopic dermatitis: Evidence and real-world insights

30 Apr 2026

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by intense pruritus, recurrent eczema, and substantial impairment in quality of life (QoL). Affecting up to 20 percent of children and approximately 10 percent of adults in high-income countries, AD places a significant burden on patients and their families, impacting sleep, productivity, and psychosocial well-being. [Br J Dermatol 2021;184:304-309]

Dupilumab improves quality of life in atopic dermatitis: Evidence and real-world insights

30 Apr 2026

Original New Drug Application Approvals by US FDA (16-31 March 2026)

29 Apr 2026

New drug applications approved by US FDA as of 16-31 March 2026 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 March 2026)

29 Apr 2026

Combined chronotherapeutic approaches help improve sleep, circadian timing in teens

28 Apr 2026

A short-term intervention combining sleep scheduling, morning bright-light glasses, and evening blue light–blocking glasses proves beneficial in terms of increasing sleep duration during weeknights and shifting circadian timing earlier in adolescents, according to a study.

Combined chronotherapeutic approaches help improve sleep, circadian timing in teens

28 Apr 2026

Prenatal exposure to buprenorphine does not lead to adverse neurodevelopmental outcomes in kids

28 Apr 2026 by

Children with prenatal exposure to buprenorphine do not appear to have an elevated risk of long-term adverse neurodevelopmental outcomes relative to those exposed to methadone, suggests a study.

Prenatal exposure to buprenorphine does not lead to adverse neurodevelopmental outcomes in kids

28 Apr 2026

Influenza C virus in children with bronchiolitis tied to severe disease

27 Apr 2026 by

Some hospitalized children with acute bronchiolitis (AB) and febrile seizures (FB) present with influenza C virus (ICV), which may contribute to more severe clinical presentations, particularly in those with AB, a recent study in Slovenia has found.

Influenza C virus in children with bronchiolitis tied to severe disease

27 Apr 2026

Paediatric PM came back with a vengeance after COVID pandemic: study

27 Apr 2026

The clinical presentation of paediatric Mycoplasma pneumoniae (MP) in 2024 shows a stark difference when compared with prior epidemics, marked by an increase in severe pneumonia among older children, reveals a study.

Paediatric PM came back with a vengeance after COVID pandemic: study

27 Apr 2026

Maternal obesity may elevate bile acids in breast milk

24 Apr 2026

Maternal obesity appears to increase bile acid (BA) levels in breast milk, which may have implications for neonatal digestion, maturation, and health.

Maternal obesity may elevate bile acids in breast milk

24 Apr 2026

Health supplements: Help or hype?

22 Apr 2026 by

A review of 19 meta-analyses shows mixed results on the effects of multivitamin and mineral (MVM) supplementation on health outcomes.

Health supplements: Help or hype?

22 Apr 2026

Roflumilast cream effective in Chinese patients with plaque psoriasis

18 Apr 2026 by

Once-daily application of roflumilast cream 0.3% is associated with a significantly higher rate of treatment success on the Investigator's Global Assessment (IGA) scale in Chinese patients with plaque psoriasis compared with a vehicle cream, according to the phase III DERMIS-1 and -2 studies presented at AAD 2026.

Roflumilast cream effective in Chinese patients with plaque psoriasis

18 Apr 2026

IL-23 inhibitors work best at preventing PsA development in psoriasis

17 Apr 2026 by

Patients with psoriasis appear to have the lowest risk of developing psoriatic arthritis (PsA) when they are treated with IL-23 inhibitors than with other immunomodulatory agents, according to a real-world study.

IL-23 inhibitors work best at preventing PsA development in psoriasis

17 Apr 2026

News & Updates

Showing Paediatrics articles

Showing

Specialty:

Dupilumab improves quality of life in atopic dermatitis: Evidence and real-world insights

Dupilumab improves quality of life in atopic dermatitis: Evidence and real-world insights

Original New Drug Application Approvals by US FDA (16-31 March 2026)

Original New Drug Application Approvals by US FDA (16-31 March 2026)

Combined chronotherapeutic approaches help improve sleep, circadian timing in teens

Combined chronotherapeutic approaches help improve sleep, circadian timing in teens

Prenatal exposure to buprenorphine does not lead to adverse neurodevelopmental outcomes in kids

Prenatal exposure to buprenorphine does not lead to adverse neurodevelopmental outcomes in kids

Influenza C virus in children with bronchiolitis tied to severe disease

Influenza C virus in children with bronchiolitis tied to severe disease

Paediatric PM came back with a vengeance after COVID pandemic: study

Paediatric PM came back with a vengeance after COVID pandemic: study

Maternal obesity may elevate bile acids in breast milk

Maternal obesity may elevate bile acids in breast milk

Health supplements: Help or hype?

Health supplements: Help or hype?

Roflumilast cream effective in Chinese patients with plaque psoriasis

Roflumilast cream effective in Chinese patients with plaque psoriasis

IL-23 inhibitors work best at preventing PsA development in psoriasis

IL-23 inhibitors work best at preventing PsA development in psoriasis